These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6201838)

  • 21. The pharmacology of asthma and possible therapeutic developments.
    Brocklehurst WE
    Ciba Found Study Group; 1971; 38():132-50. PubMed ID: 4117313
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
    Zimmermann I; Roesch A; Ulmer WT
    Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-IgE therapy].
    Chazan R
    Pol Merkur Lekarski; 2003 Jun; 14(84):617-20. PubMed ID: 14524285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgE-mediated histamine release from whole blood in atopic asthmatics.
    Tanizaki Y; Komagoe H; Sudo M; Morinaga H; Kitani H; Goda Y; Tada S; Takahashi K; Kimura I
    Arerugi; 1983 Nov; 32(11):1079-83. PubMed ID: 6203503
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma.
    O'Driscoll BR; Powell G; Chew F; Niven RM; Miles JF; Vyas A; Denning DW
    Clin Exp Allergy; 2009 Nov; 39(11):1677-83. PubMed ID: 19689458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fenoterol hydrobromide on histamine release from human leukocytes.
    Tomita Y; Masaki T; Nishikawa K; Sugimoto H; Matsunaga M; Saito H; Yamada S; Arai Y; Mishima T; Shioda H
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():398-9. PubMed ID: 6193998
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On asthma and allergic reactions. Omalizumab: from IgE to anti-IgE].
    Ladetzki-Baehs K; Dirsch VM; Vollmar AM
    Pharm Unserer Zeit; 2004; 33(2):116-22. PubMed ID: 15083621
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacokinetics of theophylline in infantile bronchial asthma. Clinical findings].
    Martínez Sampere JJ; Girón F; Olea N; Loscertales M; Ruiz Estremera A; Puentes C; Pedraza V
    An Esp Pediatr; 1982 Jul; 17(1):6-17. PubMed ID: 6182822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-IgE autoantibody in patients with bronchial asthma.
    Nawata Y; Koike T; Yanagisawa T; Iwamoto I; Itaya T; Yoshida S; Tomioka H
    Clin Exp Immunol; 1984 Nov; 58(2):348-56. PubMed ID: 6388923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversed in vitro anaphylaxis induced by anti-IgG: specificity of the reaction and comparison with antigen-induced histamine release.
    Grant JA; Lichtenstein LM
    J Immunol; 1972 Jul; 109(1):20-5. PubMed ID: 4113794
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibition of histamine liberation in allergic rhinoconjunctivitis in relation to the season].
    Räderer I; Haen E; Schudt C; Przybilla B
    Wien Med Wochenschr; 1995; 145(17-18):456-8. PubMed ID: 8588365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitization to blackgram in patients with bronchial asthma and rhinitis: clinical evaluation and characterization of allergens.
    Kumari D; Kumar R; Sridhara S; Arora N; Gaur SN; Singh BP
    Allergy; 2006 Jan; 61(1):104-10. PubMed ID: 16364164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro comparative study of the protective effect of different theophyllines on the leucocytes' histamine-release induced by antigen (author's transl)].
    Biot N; Grosclaude M; Kofman J; Perrin-Fayolle M
    Poumon Coeur; 1980; 36(4):271-5. PubMed ID: 6160569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW; Massanari M; Kianifard F; Geba GP
    Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of recombinant IFN-gamma on igE-dependent leukotriene generation by peripheral blood leukocytes in patients with pollinosis and asthma.
    Krasnowska M; Medrala W; Małolepszy J; Krasnowski R
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):287-92. PubMed ID: 11059646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omalizumab decreased IgE-release and induced changes in cellular immunity in patients with allergic asthma.
    Hanf G; Brachmann I; Kleine-Tebbe J; Seybold J; Kunkel G; Suttorp N; Noga O
    Allergy; 2006 Sep; 61(9):1141-4. PubMed ID: 16918520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.